10 Biggest Price Target Changes For Monday
Telsey Advisory Group reduced DICK'S Sporting Goods, Inc. (NYSE: DKS) price target from $153 to $125. Dick's Sporting shares rose 2.7% to $79.62 in pre-market trading.
HC Wainwright & Co. Maintains Buy on Stealth BioTherapeutics, Lowers Price Target to $1.5
HC Wainwright & Co. analyst Yi Chen maintains Stealth BioTherapeutics (NASDAQ:MITO) with a Buy and lowers the price target from $4 to $1.5.
110 Biggest Movers From Friday
Gainers
ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.
56 Stocks Moving In Friday’s Mid-Day Session
Gainers
Veru Inc. (NASDAQ: VERU) shares jumped 62.5% to $14.67 after the company reported quarterly results on Thursday. Jefferies maintained Veru with a Buy and raised the price target from $33 to $55.
90 Biggest Movers From Yesterday
Gainers
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.
Stealth BioTherapeutics Shares Rally following FDA Orphan Drug Designation To Elamipretide For Duchenne muscular dystrophy (DMD)
Stealth BioTherapeutics Corp (NASDAQ: MITO) received Orphan Drug Designation to Elamipretide from the United States Food and Drug Administration (FDA) for the treatment of patients with Duchenne muscular dystrophy (DMD).
The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More
Here's a roundup of top developments in the biotech space over the last 24 hours: